JO3008B1 - تركيب صيدلي لتخفيف الألم - Google Patents
تركيب صيدلي لتخفيف الألمInfo
- Publication number
- JO3008B1 JO3008B1 JOP/2010/0285A JOP20100285A JO3008B1 JO 3008 B1 JO3008 B1 JO 3008B1 JO P20100285 A JOP20100285 A JO P20100285A JO 3008 B1 JO3008 B1 JO 3008B1
- Authority
- JO
- Jordan
- Prior art keywords
- hyaluronic acid
- pharmaceutical composition
- relieving pain
- carboxyl group
- joint disease
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 5
- 229920002674 hyaluronan Polymers 0.000 abstract 5
- 229960003160 hyaluronic acid Drugs 0.000 abstract 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 3
- 208000012659 Joint disease Diseases 0.000 abstract 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 abstract 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 abstract 1
- 230000009435 amidation Effects 0.000 abstract 1
- 238000007112 amidation reaction Methods 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 229930016911 cinnamic acid Natural products 0.000 abstract 1
- 235000013985 cinnamic acid Nutrition 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/738—Cross-linked polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
يتعلق الاختراع الحالي بتركيب صيدلي لتخفيف الألم الناجم عن أمراض تصيب المفاصل, يتضمن حمض الهيالورونيك ومادة حاملة مقبولة صيدلياً, بحيث تتقاطع روابط حمض الهيالورونيك عن طريق حلقنة الرابطة الثنائية في شقّ حمض السناميك لتشكيل حمض هيالورونيك محول إلى أميد جزئياً ممثـل بالصيغة (1): [Ar-CH=CH-COO-(CH2)n-NH-]m-HA, لتشكيل حلقة البيوتان الحلقي, حيث Ar يمثل مجموعة فنيل تحمل بدائل بشكل اختياري, n يمثل عدداً صحيحاً يبلغ 2 أو 3, HA يمثل شق كربوكسي لحمض الهيالورونيك, وm يمثل نسبة أميدة حمض الهيالورونيك إلى إجمالي مجموعة الكربوكسيل والتي تمثل 3 إلى 50? بالنسبة إلى إجمالي مجموعة الكربوكسيل. ويمثل التركيب الصيدلي وفقاً للاختراع الحالي تركيبة تعطى داخل المفصل تبدي تأثيرات مسكنة سريعة بعد الإعطاء, وتظهر تأثيرات طويلة الأمد جداً للأمراض التي تصيب المفاصل عند الإنسان عند الإعطاء المفرد فقط بدلاً من الإعطاءات المتعددة وفقاً للطريقة التقليدية.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009187899 | 2009-08-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JO3008B1 true JO3008B1 (ar) | 2016-09-05 |
Family
ID=43586085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JOP/2010/0285A JO3008B1 (ar) | 2009-08-13 | 2010-08-10 | تركيب صيدلي لتخفيف الألم |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US8828969B2 (ar) |
| EP (2) | EP2918277A1 (ar) |
| JP (4) | JP5788798B2 (ar) |
| KR (2) | KR20180000746A (ar) |
| CN (2) | CN102481313A (ar) |
| AU (1) | AU2010283380B2 (ar) |
| BR (1) | BR112012003149B8 (ar) |
| CA (1) | CA2770583C (ar) |
| ES (1) | ES2537128T3 (ar) |
| JO (1) | JO3008B1 (ar) |
| MX (1) | MX2012001853A (ar) |
| NZ (1) | NZ597680A (ar) |
| RU (1) | RU2558064C2 (ar) |
| TW (2) | TWI565470B (ar) |
| WO (1) | WO2011018902A1 (ar) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101460815B1 (ko) | 2006-12-06 | 2014-11-12 | 세이가가쿠 고교 가부시키가이샤 | 관절염 질환 치료의 지속성 효과를 갖는 제약 제제 |
| BR112015016734A2 (pt) | 2013-01-11 | 2017-07-11 | Carbylan Therapeutics Inc | composições estabilizadas compreendendo ácido hialurônico |
| GB2518405A (en) * | 2013-09-20 | 2015-03-25 | Zeiss Carl Meditec Ag | Composition comprising at least one viscoelastic polymer |
| WO2018048322A1 (ru) * | 2016-09-12 | 2018-03-15 | Леонид Валерьевич КЕЛИН | Композиция для лечения или профилактики вирусных инфекций |
| CN117427183A (zh) | 2017-03-14 | 2024-01-23 | 生化学工业株式会社 | 关节疾病处置用组合物及含有其的试剂盒 |
| KR20200113036A (ko) | 2017-03-14 | 2020-10-05 | 세이가가쿠 고교 가부시키가이샤 | 관절 질환 처치용 조성물 및 그것을 포함하는 키트 |
| JP7216006B2 (ja) | 2017-03-22 | 2023-01-31 | ジェネンテック， インコーポレイテッド | ヒドロゲル架橋ヒアルロン酸プロドラッグ組成物及び方法 |
| WO2019046834A1 (en) * | 2017-09-01 | 2019-03-07 | Pmidg, Llc | FUNCTIONALIZED AND RETICULATED POLYMERS |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5356883A (en) | 1989-08-01 | 1994-10-18 | Research Foundation Of State University Of N.Y. | Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use |
| JP2855307B2 (ja) | 1992-02-05 | 1999-02-10 | 生化学工業株式会社 | 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法 |
| US6025444A (en) | 1994-11-17 | 2000-02-15 | Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) | Cinnamic acid derivative |
| JP3308742B2 (ja) * | 1994-11-17 | 2002-07-29 | 生化学工業株式会社 | 光架橋性ヒアルロン酸誘導体とその架橋体およびそれらの製造方法 |
| US5690961A (en) | 1994-12-22 | 1997-11-25 | Hercules Incorporated | Acidic polysaccharides crosslinked with polycarboxylic acids and their uses |
| HU224697B1 (en) | 1995-11-15 | 2006-01-30 | Seikagaku Kogyo Co Ltd | Photocured cross-linked-hyaluronic acid gel and method of preparation thereof |
| PT939086E (pt) | 1998-02-27 | 2004-07-30 | Stichting Hippomedics | Processo para produzir o acido hialuronico reticulado |
| US7014860B1 (en) | 2000-02-03 | 2006-03-21 | Denki Kagaku Kogyo Kabushiki Kaisha | Hyaluronic acid gel, process for producing the same, and medical material containing the same |
| DE60117502T2 (de) | 2000-12-19 | 2006-08-24 | Seikagaku Corp. | Photohärtbare Derivate von Hyaluronsäure, Verfahren zu deren Herstellung, vernetztes und photogehärtetes Derivat der Hyaluronsäure und diese enthaltendes medizinisches Material |
| JP4172176B2 (ja) | 2000-12-19 | 2008-10-29 | 生化学工業株式会社 | 光反応性ヒアルロン酸およびその製造方法ならびに光架橋ヒアルロン酸および医用材料 |
| SI2664334T1 (sl) | 2004-12-30 | 2015-06-30 | Genzyme Corporation | Reĺ˝imi za intraartikularno viskosuplemantacijo |
| RU2429018C2 (ru) * | 2005-07-06 | 2011-09-20 | Сейкагаку Корпорейшн | Гель, полученный из фотосшитой гиалуроновой кислоты с введенным лекарственным средством |
| KR101460815B1 (ko) | 2006-12-06 | 2014-11-12 | 세이가가쿠 고교 가부시키가이샤 | 관절염 질환 치료의 지속성 효과를 갖는 제약 제제 |
-
2010
- 2010-08-10 JO JOP/2010/0285A patent/JO3008B1/ar active
- 2010-08-13 TW TW099127068A patent/TWI565470B/zh active
- 2010-08-13 CN CN2010800352195A patent/CN102481313A/zh active Pending
- 2010-08-13 BR BR112012003149A patent/BR112012003149B8/pt active IP Right Grant
- 2010-08-13 WO PCT/JP2010/005060 patent/WO2011018902A1/ja not_active Ceased
- 2010-08-13 KR KR1020177036970A patent/KR20180000746A/ko not_active Ceased
- 2010-08-13 TW TW105129117A patent/TWI612965B/zh active
- 2010-08-13 ES ES10808087.0T patent/ES2537128T3/es active Active
- 2010-08-13 US US13/390,261 patent/US8828969B2/en active Active
- 2010-08-13 MX MX2012001853A patent/MX2012001853A/es active IP Right Grant
- 2010-08-13 RU RU2012109392/15A patent/RU2558064C2/ru active
- 2010-08-13 EP EP15157125.4A patent/EP2918277A1/en not_active Withdrawn
- 2010-08-13 JP JP2011526692A patent/JP5788798B2/ja active Active
- 2010-08-13 NZ NZ597680A patent/NZ597680A/en unknown
- 2010-08-13 EP EP10808087.0A patent/EP2465512B1/en active Active
- 2010-08-13 KR KR1020127004612A patent/KR101813487B1/ko active Active
- 2010-08-13 CA CA2770583A patent/CA2770583C/en active Active
- 2010-08-13 CN CN201611263701.XA patent/CN106890131A/zh active Pending
- 2010-08-13 AU AU2010283380A patent/AU2010283380B2/en active Active
-
2014
- 2014-08-05 US US14/452,324 patent/US9579342B2/en active Active
-
2015
- 2015-07-30 JP JP2015150298A patent/JP6058090B2/ja active Active
-
2016
- 2016-12-06 JP JP2016236428A patent/JP6280628B2/ja active Active
- 2016-12-06 US US15/370,442 patent/US10420795B2/en active Active
-
2018
- 2018-01-19 JP JP2018006893A patent/JP6417488B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO3008B1 (ar) | تركيب صيدلي لتخفيف الألم | |
| AU2018201997B2 (en) | Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions | |
| WO2007145991A3 (en) | Anti-inflammatory and analgesic compositions and related methods | |
| MX346879B (es) | Formulaciones de ketorolaco listas para su uso. | |
| WO2012007159A3 (en) | Novel gastro-retentive dosage forms | |
| NZ605887A (en) | Pharmaceutical dosage form comprising 6’-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4’,9’-dihydro-3’h-spiro[cyclohexane-1,1’-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain | |
| MX2010002392A (es) | Composiciones de brimonidina mejoradas para tratar eritema. | |
| WO2011094337A8 (en) | Glucagon antagonist - gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| NZ599847A (en) | Pharmaceutical composition comprising a glp-1 agonist and methionine | |
| AR075735A1 (es) | Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso | |
| NZ610911A (en) | Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same | |
| EA201171109A1 (ru) | Новая композиция замедленного высвобождения соединений, выбранных из класса миорелаксантов центрального действия | |
| EA201071039A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40 | |
| WO2012035559A3 (en) | Sustained release pharmaceutical compositions comprising pregabalin | |
| MX2011011126A (es) | Composiciones y metodos para tratar quemaduras. | |
| MX2009007784A (es) | Composiciones de tiacumicinas estables. | |
| MX2010009623A (es) | Derivados de 1-bencil-3-hidroximetilindazol novedosos y su uso en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40. | |
| PH12014500065A1 (en) | A new therapeutical composition containing apomorphine as active ingredient | |
| PE20081799A1 (es) | Mejoras en composiciones medicinales o relativas a las mismas | |
| EA200870469A1 (ru) | Новые, содержащие нимесулид, фармацевтические композиции с низкой дозой, их получение и применение | |
| MX2009010165A (es) | Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704. | |
| MA34055B1 (fr) | Chlorhydrate d'agomelatine hydrate et sa preparation | |
| WO2013032558A4 (en) | Products for anti-inflammation support | |
| SG158863A1 (en) | Intravenous formulations of pde-5 inhibitors |